scispace - formally typeset
Y

Yusei Ohshima

Researcher at University of Fukui

Publications -  141
Citations -  3762

Yusei Ohshima is an academic researcher from University of Fukui. The author has contributed to research in topics: CD28 & Cytotoxic T cell. The author has an hindex of 30, co-authored 131 publications receiving 3397 citations. Previous affiliations of Yusei Ohshima include Université de Montréal & Japan Agency for Medical Research and Development.

Papers
More filters
Journal Article

Expression and function of OX40 ligand on human dendritic cells.

TL;DR: The expression of OX40L on DC suggests a physiologic role of this molecule during T cell priming by virtue of its ability to costimulate both T cell and DC activation and differentiation.
Journal ArticleDOI

OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors.

TL;DR: It is shown that ligation of OX40 Ag, a member of the tumor necrosis factor receptor (TNF-R) family, on activated umbilical cord blood CD4+ T cells upregulates IL-4 production at priming and thereby promotes their development into effector cells producing high levels of the type 2 cytokines IL- 4, IL-5, and IL-13.
Journal Article

Prostaglandin E2 at priming of naive CD4+ T cells inhibits acquisition of ability to produce IFN-gamma and IL-2, but not IL-4 and IL-5.

TL;DR: PGE2 must exist at an early stage of T cell activation to inhibit priming for IL-2 and IFN-gamma production, and it is suggested that PGE2 plays a role in facilitating the development of the Th2-type cytokine production profile.
Journal ArticleDOI

Oxidative stress and altered antioxidant defenses in children with acute exacerbation of atopic dermatitis.

TL;DR: The findings indicate that oxidative stress and altered antioxidant defenses are involved in the pathophysiology of acute exacerbation of AD, and that suppression of oxidative stress might be a potentially useful strategy for the treatment of AD.